| 1 |
25061302 | Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect. | 2014 |
1 |
| 2 |
26000221 | Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect. | 2014 Jun |
1 |
| 3 |
12673723 | Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells. | 2003 Apr 15 |
1 |
| 4 |
9758674 | Inhibition of desipramine hydroxylation (Cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivo. | 1998 Oct |
1 |
| 5 |
9103485 | Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liability. | 1997 Apr |
1 |
| 6 |
8138941 | Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo. | 1994 Mar |
1 |
| 7 |
1611804 | Dextromethorphan: enhancing its systemic availability by way of low-dose quinidine-mediated inhibition of cytochrome P4502D6. | 1992 Jun |
3 |